Overview

Full Product Details

9780822356080

Table of Contents

Reviews

At last! A paradigm-shifting theorizing of biolabor - largely invisibled, underpaid or donated work that produces invaluable human materials for highly lucrative pharmaceutical and assisted reproductive technology industries. Cooper and Waldby brilliantly analyze such labor as continuous with low-waged distributed piece work characteristic of 21st century post-Fordist bioeconomies, including venture labor (high risk/no pay). These highly gendered and racialized divisions of labor are eerily bioethics approved as they outsource risk to individual worker 'entrepreneurs' and put 'life itself' to work for biocapital. Brava!! - Adele E. Clarke, coeditor of Biomedicalization: Technoscience, Health, and Illness in the U.S.

Author Information

Melinda Cooper is a Senior Research Fellow in the Department of Sociology and Social Policy at the University of Sydney. She is the author of Life as Surplus: Biotechnology and Capitalism in the Neoliberal Era. Catherine Waldby is a Professorial Future Fellow in the Department of Sociology and Social Policy at the University of Sydney. She is coauthor, with Herbert Gottweis and Brian Salter, of The Global Politics of Human Embryonic Stem Cell Science: Regenerative Medicine in Transition and, with Robert Mitchell, of Tissue Economies: Blood, Organs, and Cell Lines in Late Capitalism, which is also published by Duke University Press.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available